Equities

K Pharma Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4896:TYO

K Pharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)688.00
  • Today's Change-5.00 / -0.72%
  • Shares traded12.40k
  • 1 Year change+2.53%
  • Beta--
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

K Pharma Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through a single segment of research, development, manufacture, and sale of pharmaceuticals, among others. The Company is engaged in induced pluripotent stem cell (iPS) drug discovery business. Neural progenitor cells, the cells that form the basis of nerves, are created from iPS cells, cryopreserved, and then 200000 cells are transplanted by injection into the site of a patient's spinal cord injury. The Company is also engaged in the research, development, manufacture and sale of regenerative medicine products.

  • Revenue in JPY (TTM)0.00
  • Net income in JPY-904.05m
  • Incorporated2016
  • Employees17.00
  • Location
    K Pharma Inc8F, Tri-seven Roppongi, 7-7-7, RoppongiMINATO-KU 106-0032JapanJPN
  • Phone+81 366293380
  • Fax+81 366293381
  • Websitehttps://www.kpharma.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Muromachi Chemicals Inc7.37bn364.59m4.40bn203.0012.001.638.140.597489.5989.591,819.39658.421.233.815.8436,304,700.006.095.998.6610.3629.8529.904.954.891.7618.370.476926.504.464.73-26.9350.1932.64--
Symbio Pharmaceuticals Ltd1.53bn-4.55bn5.51bn108.00--2.70--3.61-95.13-95.1331.8731.810.28651.754.7514,123,620.00-85.54-17.36-99.44-21.1173.7170.15-298.56-22.797.22--0.5861---56.12-2.87-95.31---26.36--
Kohjin Bio Co Ltd5.20bn719.61m6.24bn167.008.671.075.681.20140.79140.791,017.951,137.250.59953.695.5331,156,770.008.29--11.44--44.58--13.83--1.61--0.2512--9.14--106.44------
MEDRx Co Ltd121.55m-1.26bn6.89bn22.00--3.20--56.65-25.69-25.692.4036.200.04940.05381.825,525,137.00-51.01-50.16-52.60-53.4699.2697.56-1,033.29-1,068.3630.81-180.530.00--773.288.7113.52---74.64--
Nippon Chemiphar Co Ltd32.88bn501.00m7.24bn855.0012.240.3243.650.2204138.86138.869,112.065,247.720.63222.063.0938,451,460.000.96530.67941.330.968626.7028.431.531.041.46--0.490855.165.930.5075263.33-7.5832.850.00
COSMO BIO COMPANY, LIMITED10.51bn243.00m7.90bn174.0030.630.798819.800.751342.6442.641,842.531,635.050.8916.524.0260,419,540.002.085.382.416.4134.2036.392.345.955.52--0.00241.037.465.75-40.722.038.6828.99
K Pharma Inc0.00-904.05m8.05bn17.00--5.10-----77.90-77.900.00135.840.000.00--0.00-42.22---43.87----------22.19--0.00---100.00---425.15------
Solasia Pharma KK326.00m-1.80bn8.08bn23.00--4.34--24.77-8.12-8.121.446.910.13830.54315.6714,173,910.00-76.18-64.46-87.38-80.7973.9359.35-550.92-401.814.27-77.040.0547---48.78-24.75-74.55---73.26--
CellSource Co Ltd3.71bn10.66m8.27bn148.00833.431.3739.572.230.50030.5003186.84303.580.52655.9111.3125,077,400.000.151210.680.161311.8956.2464.880.287214.3711.7916.090.009320.88-14.7814.87-95.52-47.768.90--
CellSeed Inc120.30m-1.03bn10.91bn38.00--7.80--90.65-29.71-29.713.4737.830.05621.224.753,165,816.00-48.11-45.50-51.99-49.2952.7257.47-856.11-478.147.05--0.0949--1.65-6.87-1.57--6.39--
Stella Pharma Corp991.86m-180.01m11.16bn43.00--3.85--11.25-5.29-5.2929.1585.220.19580.10842.6723,066,440.00-3.55-16.41-3.74-18.1987.1587.03-18.15-176.1612.27-26.440.1917--256.62--81.56---21.34--
Wakamoto Pharmaceutical Co Ltd8.36bn72.14m11.88bn286.00164.041.0223.111.422.082.08240.90333.900.55491.603.2529,233,100.000.4788-0.06780.5454-0.078146.0748.650.8628-0.12462.60--0.0086--0.6595-6.53-40.86--21.87--
Data as of Feb 06 2026. Currency figures normalised to K Pharma Inc's reporting currency: Japanese Yen JPY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.